Weißes Blutkörperchen_Leukozyt

Stop Experimenting.
Go Silico.

Accelerating downstream process development with computer simulation

scroll for more
Snapshot of ChromX video

The future of biopharmaceutical process development is driven by in silico solutions. We provide the tools to master the transition to bioprocessing 4.0.

Our disruptive simulation software DSPX enables the computer-based development and simulation of downstream processes. Benefit from the technology and digitalize your downstream process development.

YouTube

By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video

Two logos of Cytiva and GoSilico

Global life sciences leader Cytiva has acquired GoSilico. Find more information in our joint press release.

Our goal: empowering you to go silico

DSPX software user in front of an Äkta system

Become an expert user

DSPX software and training

Read more
GoSilico consulting

Take our advice

GoSilico consulting

Read more
Developer at GoSilico looking at screen

Outsource modeling work

Contract modeling

Read more

Let’s keep in touch!
Subscribe to our Newsletter.

E-Mail

 | 

The future lies in silico – stay up-to-date

We are the pioneers of in silico process development. In our blog, we share our thoughts and opinions on implementation hurdles, challenges, risks and how to mitigate them.

See all blog posts

Meet GoSilico: Upcoming events, conferences and trade fairs

GoSilico